Nicholas Mitsakos - Cardax Executive Chairman
| CDXI Stock | USD 0.0002 0.00 0.00% |
Chairman
Mr. Nicholas M. Mitsakos is Executive Chairman of the Board of the Cardax Inc. Mr. Mitsakos has served as the Executive Chairman of the Board of Pharma since its inception in May 2013 as Executive Chairman of the Board Holdings since May 2009 as Chairman of the Board of Holdings from May 2006 to May 2009 and as a Director of Holdings from its inception in March 2006 to May 2006. Mr. Mitsakos has served as the Chairman and Chief Executive Officer of Arcadia Holdings Inc. since 1989 focusing on private equity and VC investments globally. He has also been a senior advisor to Sardis Capital a Londonbased merchant bank since 2003 to Franklin Templeton China in Shanghai since 2001 and previously to Templeton International. Mr. Mitsakos has also served as a director of Meru Networks Inc. since 2002 Chairman of IMEx Minerals LLC since 2005 and CoChairman of Ubiquity Broadcasting Corporation since 2011. Mr. Mitsakos worked at Goldman Sachs in 1985 and Drexel Burnham Lambert from 1986 to 1989. He holds B.S. degrees in Computer Science and Microbiology from the University of Southern California where he graduated first in his class and an MBA from Harvard University. He taught at UCLAs Anderson School of Business from 1992 to 1998 and is also on the board of UCLAs Center for Cerebral Palsy within the UCLA Medical School. Mr. Mitsakos is also on the board of the Rehabilitation Hospital of the Pacific and a lecturer at the Harvard Innovation Center at Harvard University. Mr. Mitsakos provides valuable insight and leadership to our Board through his deep financial expertise and his longstanding history with the development of our business. since 2014.
| Age | 55 |
| Tenure | 10 years |
| Phone | 808 457 1400 |
| Web | https://www.cardaxpharma.com |
Cardax Management Efficiency
The company has return on total asset (ROA) of (1.1256) % which means that it has lost $1.1256 on every $100 spent on assets. This is way below average. Cardax's management efficiency ratios could be used to measure how well Cardax manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 5 records | CHAIRMAN Age | ||
| William Goolsbee | Sarepta Therapeutics | 60 | |
| Iain Dukes | Iovance Biotherapeutics | 59 | |
| Allan Jacobson | PTC Therapeutics | 78 | |
| Michael Schmertzler | PTC Therapeutics | 66 | |
| Keith Gollust | Madrigal Pharmaceuticals | 72 | |
Management Performance
| Return On Asset | -1.13 |
Cardax Inc Leadership Team
Elected by the shareholders, the Cardax's board of directors comprises two types of representatives: Cardax inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cardax. The board's role is to monitor Cardax's management team and ensure that shareholders' interests are well served. Cardax's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cardax's outside directors are responsible for providing unbiased perspectives on the board's policies.
| George Bickerstaff, Independent Director | ||
| Nicholas Mitsakos, Executive Chairman | ||
| Frank Herringer, Director | ||
| Terence Kelly, Independent Director | ||
| David Watumull, VP of Operations, Assistant Treasurer and Assistant Secretary | ||
| Michele Galen, Independent Director | ||
| Richard Morris, Secretary | ||
| Tamar Howson, Independent Director | ||
| Gilbert Shin, Vice President - Retail Sales and Marketing | ||
| Elona Kogan, Independent Director | ||
| Makarand Jawadekar, Independent Director | ||
| John Russell, CFO, Treasurer | ||
| Jon MD, Chief Officer |
Cardax Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Cardax a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -1.13 | |||
| Operating Margin | (5.85) % | |||
| Current Valuation | 5.34 M | |||
| Shares Outstanding | 802.52 K | |||
| Price To Earning | (22.00) X | |||
| Price To Sales | 0.0008 X | |||
| Revenue | 538.95 K | |||
| Gross Profit | 342.82 K | |||
| EBITDA | (2.64 M) | |||
| Net Income | (5.06 M) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cardax in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cardax's short interest history, or implied volatility extrapolated from Cardax options trading.
Pair Trading with Cardax
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cardax position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardax will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Cardax could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cardax when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cardax - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cardax Inc to buy it.
The correlation of Cardax is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cardax moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cardax Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cardax can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardax Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Complementary Tools for Cardax Pink Sheet analysis
When running Cardax's price analysis, check to measure Cardax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardax is operating at the current time. Most of Cardax's value examination focuses on studying past and present price action to predict the probability of Cardax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardax's price. Additionally, you may evaluate how the addition of Cardax to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |